NCT05079555

Brief Summary

Hip fracture is one of the most common traumas associated with falls in the elderly, severely affecting the patient's mobility and independence. The treatment involves hospitalization and prolonged rehabilitation periods with high costs which are associated with an increased mortality rate due to health complications. In recent years, the use of robotic applications has proven to be effective in gait rehabilitation, especially for neurological disorders. However, there is a lack of research in robotic rehabilitation focused on the hip fracture of elderly people. This study presents the validation of a novel robotic platform for hip rehabilitation called SWalker aimed at improving the rehabilitation of this condition in comparison with conventional rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 22, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

October 15, 2021

Completed
Last Updated

October 15, 2021

Status Verified

October 1, 2021

Enrollment Period

2.1 years

First QC Date

September 22, 2021

Last Update Submit

October 3, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • effectiveness of rehabilitation

    Number of physiotherapy sessions

    through study completion, an average of 3 months

  • Degree of gait recovery

    time to recovery of autonomous walking to perform their daily functional tasks (days)

    through study completion, an average of 3 months

Study Arms (2)

Control group

NO INTERVENTION

The control group consisted of patients who followed conventional therapy.

Intervention group

EXPERIMENTAL

The intervention group consisted of patients rehabilitated using the robotic platform.

Device: Robotic rehab

Interventions

Patients using the robotic platform SWalker

Intervention group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients who, after recently having undergone a hip fracture surgery, needed subsequent rehabilitation to restore autonomous ambulation
  • patients over 65 years of age

You may not qualify if:

  • patients who have undergone a hip fracture surgery more than 5 months ago
  • patients who have already received other types of hip fracture rehabilitation therapies
  • patients with advanced and limiting neurological and cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albertia Servicios Sociosanitarios

Madrid, 28222, Spain

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The performance of the SWalker platform was assessed at Albertia Servicios Sociosanitarios S.A. nursing homes. Clinical validation was conducted with hip fracture patients. The control group consisted of patients who followed conventional therapy, while the intervention group consisted of patients rehabilitated using SWalker. Allocation to groups was according to the choice of the participants. All patients had the possibility to use SWalker treatment. For those patients who received conventional rehabilitation, treatment duration was up to 6 months in the most severe case. Patient follow-up was conducted in parallel with the clinical trials.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 22, 2021

First Posted

October 15, 2021

Study Start

March 1, 2018

Primary Completion

April 15, 2020

Study Completion

April 15, 2020

Last Updated

October 15, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations